Literature DB >> 11937548

An analysis of T cell intrinsic roles of E2A by conditional gene disruption in the thymus.

Lihua Pan1, Jenifer Hanrahan, Jie Li, Laura P Hale, Yuan Zhuang.   

Abstract

The importance of E2A transcription factors in T cell development has been demonstrated in studies of E2A-deficient mice, which display abnormal T cell development and a high frequency of T cell lymphomas. Because E2A expression is not restricted to the T cell lineage, the primary cause of the T cell phenotype in E2A-deficient mice was not fully determined. To further investigate the role of E2A in T cell lineage, we generated mice with the E2A gene disrupted exclusively during thymocyte development using the Cre-lox system. We show that this system allows E2A gene disruption to occur throughout the double-negative stage of thymocyte development. E2A deletion appears to be completed before development reaches the double-positive stage. Consistent with the gene disruption, these mice reveal a T cell intrinsic role for E2A during the transition from the double-negative stage to the double-positive stage of thymocyte development. In contrast to germline E2A knockout mice, conditional E2A knockout mice do not develop T cell lymphoma. This work establishes a new model for further investigating E2A function in T cell development and leukemiogenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11937548     DOI: 10.4049/jimmunol.168.8.3923

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  38 in total

1.  Differential functions for the transcription factor E2A in positive and negative gene regulation in pre-B lymphocytes.

Authors:  Stephen Greenbaum; Adam S Lazorchak; Yuan Zhuang
Journal:  J Biol Chem       Date:  2004-08-13       Impact factor: 5.157

2.  Stage-specific functions of E-proteins at the β-selection and T-cell receptor checkpoints during thymocyte development.

Authors:  Mary Elizabeth Jones; Yuan Zhuang
Journal:  Immunol Res       Date:  2011-04       Impact factor: 2.829

3.  E2A and IRF-4/Pip promote chromatin modification and transcription of the immunoglobulin kappa locus in pre-B cells.

Authors:  Adam S Lazorchak; Mark S Schlissel; Yuan Zhuang
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

4.  Nucleoprotein structure of the CD4 locus: implications for the mechanisms underlying CD4 regulation during T cell development.

Authors:  Ming Yu; Mimi Wan; Jianmin Zhang; Jie Wu; Rohini Khatri; Tian Chi
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-05       Impact factor: 11.205

5.  Combined deletion of Id2 and Id3 genes reveals multiple roles for E proteins in invariant NKT cell development and expansion.

Authors:  Jia Li; Di Wu; Ning Jiang; Yuan Zhuang
Journal:  J Immunol       Date:  2013-10-11       Impact factor: 5.422

6.  LKB1 regulates TCR-mediated PLCγ1 activation and thymocyte positive selection.

Authors:  Yonghao Cao; Hai Li; Haifeng Liu; Min Zhang; Zichun Hua; Hongbin Ji; Xiaolong Liu
Journal:  EMBO J       Date:  2011-04-12       Impact factor: 11.598

7.  E2A proteins enforce a proliferation checkpoint in developing thymocytes.

Authors:  Isaac Engel; Cornelis Murre
Journal:  EMBO J       Date:  2003-12-11       Impact factor: 11.598

8.  Folate-dependent methylation of septins governs ciliogenesis during neural tube closure.

Authors:  Manami Toriyama; Michinori Toriyama; John B Wallingford; Richard H Finnell
Journal:  FASEB J       Date:  2017-04-21       Impact factor: 5.191

9.  E proteins are required to activate germline transcription of the TCR Vbeta8.2 gene.

Authors:  Jingquan Jia; Meifang Dai; Yuan Zhuang
Journal:  Eur J Immunol       Date:  2008-10       Impact factor: 5.532

10.  Pre-TCR signaling inactivates Notch1 transcription by antagonizing E2A.

Authors:  Yumi Yashiro-Ohtani; Yiping He; Takuya Ohtani; Mary E Jones; Olga Shestova; Lanwei Xu; Terry C Fang; Mark Y Chiang; Andrew M Intlekofer; Stephen C Blacklow; Yuan Zhuang; Warren S Pear
Journal:  Genes Dev       Date:  2009-07-15       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.